南戈壁-S(01878.HK):申請於多倫多證券創業交易所上市及於香港聯交所第一上市
格隆匯4月21日丨南戈壁-S(01878.HK)發佈公吿,公司宣佈將向多倫多證券創業交易所(“TSX-V”)申請其普通股於TSX-V上市。結合上述情況,公司亦將申請其普通股從多倫多證券交易所(“TSX”)批准自願退市,惟須待公司獲TSX-V對上市申請的批准。根據香港聯交所上市規則第19C.13A條,公司擬向香港聯交所提交書面通知(“第一上市申請”),説明(其中包括)於批准上市申請及上市申請生效,其將能完全遵守適用的上市規則,並將其目前於香港聯交所的第二上市將轉換為第一上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.